FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/06/2026
Back to search
Official data from USPTO
EXIMMIUM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EXIMMIUM
ST13
US500000079404774Class
1, 5, 42, 44
Filing
79404774
Registration
8097692
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
08/06/2026
Trademark type
Word
Nice classes
1, 5, 42, 44
Filing date
04/18/2024
Registration date
01/13/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/13/2026
Last transaction
08/06/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
BLAZICH, JOAN MICHELE
Law office
N40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Eximmium Biotechnologies GmbH
Representatives
Ryan D. Artis Riverside Law LLP
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical substancesmaterials and preparationschemicals for industrial purposes; chemical compositions and materialschemicals for use in science; chemical componentschemicals for producing a radio-labelled monoclonal antibody for industrial or scientific use; tagged antibodies for scientific purposes for laboratory use; monoclonal antibodies for scientific use; tagged antibodies for scientific use; immunological antibodies for scientific purposesother than for medical use; monoclonal antibodies for scientific purposes for diagnostic useother than medical use; antibodies for scientific purposesother than for medical or veterinary use; diagnostic preparations for scientific purposes; clinical diagnosticsdiagnostic reagents for scientific use other than for medical or veterinary use; diagnostic reagents for in-vitro use for scientific useother than medical use; diagnostic reagentsother than for medical use in kit formdiagnostic reagent kits for scientific use comprised of reagents for scientific use and test tubes
Class 5
Medical and veterinary preparationspharmaceutical and biological preparations for the treatment of cancer and infectious disease; Pharmaceuticals and natural remedies in the nature of pharmaceutical and biological preparations for the treatment of cancer and infectious disease; biotechnological preparations for the treatment of cancer and infectious disease for medical use; antibodies for medical purposes; diagnostic agents for medical use; diagnostic preparations and materialsdiagnostic preparations for medical purposes; diagnostic agents for pharmaceutical use; diagnostic preparations for medical purposes; anti-cancer drugs; Pharmaceutical compounds for treating cancer; pharmaceutical preparations and substances for use in oncology; clinical diagnostic reagents for medical use
Class 42
Science and technology servicesscientific research and development; natural science servicesscientific research; medical and pharmacological research services; information on the subject of scientific research in the field of biochemistry and biotechnology; research relating to biotechnology; biotechnology product testing; research and development in the field of biotechnology; research and development in the pharmaceutical and biotechnology fields; research and development services in the field of antibody technology; research and development services in the field of antibodies; scientific research laboratory services relating to the production of monoclonal antibodies; research and development in the field of diagnostic preparations
Class 44
Human healthcare services; animal healthcare services; medical services; medical and healthcare services; human hygiene and beauty care; advisory services relating to medical services; medical services in the field of oncology; medical analysis services for the diagnosis of cancer; medical analysis services for cancer diagnosis and prognosis; medical diagnostic services.
Publications
History of USPTO decisions and trademark events.
31 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/18/2026
FIMP
FINAL DISPOSITION PROCESSED
07/17/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/13/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/05/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/18/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
02/18/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/13/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
01/13/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/25/2025
PUBO
PUBLISHED FOR OPPOSITION
11/25/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/19/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/24/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
10/23/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/23/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
10/23/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/23/2025
DOCK
ASSIGNED TO EXAMINER
10/03/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/12/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/12/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/12/2025
DOCK
ASSIGNED TO EXAMINER
11/30/2024
RFNT
REFUSAL PROCESSED BY IB
11/30/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/13/2024
RFRR
REFUSAL PROCESSED BY MPU
11/13/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/07/2024
CNRT
NON-FINAL ACTION WRITTEN
11/06/2024
DOCK
ASSIGNED TO EXAMINER
10/31/2024
MAFR
APPLICATION FILING RECEIPT MAILED
09/20/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/20/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/19/2024
Continuous trademark protection
Get notified about every new filing that threatens EXIMMIUM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.